Skyclarys (omaveloxolone) is the first approved medication used to treat a rare, genetic problem called Friedreich's ataxia (FA) in people 16 years of age and older. It comes as capsules that are taken by mouth once per day. The most common side effects of Skyclarys (omaveloxolone) include headache, nausea, stomach pain, and higher liver lab results.
Skyclarys (omaveloxolone) is a nuclear factor erythroid 2-related factor 2 (Nrf2) activator. Nrf2 is a signaling pathway in the body that's involved in lowering inflammation to prevent tissue and cell damage. It's not exactly known how Skyclarys (omaveloxolone) works to treat Friedreich's ataxia. But it's thought to work by turning on the Nrf2 signaling pathway. This might prevent further damage to the nervous system that's affected by Friedreich's ataxia.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Friedreich's ataxia (FA) is a rare, genetic problem that mainly affects your nerves and heart. This genetic problem happens when there's not enough of a protein called frataxin in the body. Frataxin is important for certain nerve and muscle cells to work properly. So without enough frataxin, there are problems with your nervous system and sometimes heart. The first and most common symptom of FA is loss of balance and coordination. Other symptoms include weakness, difficulty with speech, difficulty swallowing, and muscle and bone problems. FA can also cause heart failure and diabetes. Studies show that treatment with Skyclarys (omaveloxolone) can help improve nerve function in people with FA.
A two-part study looked at how well Skyclarys (omaveloxolone) worked to improve FA symptoms in people between the ages of 16 and 40 with the condition. The first part of the study showed that after about 3 months, Skyclarys (omaveloxolone) helped improve brain and nerve function, but not exercise ability. The second part of the study looked further into the effect of Skyclarys (omaveloxolone) on nerve function. Results showed that after almost a year of treatment, people taking Skyclarys (omaveloxolone) had significantly better nerve function than those who took placebo. Some properties of nerve function that the study looked at were arm and leg coordination, stability when standing, and speech, chewing, and swallowing abilities. If you're taking Skyclarys (omaveloxolone), follow up with your provider regularly to discuss how well treatment is working for you.
In studies, Skyclarys (omaveloxolone) generally started to help improve nerve function within 3 months. Some specific properties of nerve function included in the studies were arm and leg coordination, stability when standing, and speech, chewing, and swallowing abilities. Improvements in nerve function might last for as long as 3 years with continued treatment. But everyone responds differently to Skyclarys (omaveloxolone), and your experience with treatment might be different from others. For this reason, follow up with your provider regularly to make sure Skyclarys (omaveloxolone) is helping your FA.
Yes, there are a few blood tests you'll need to get before you can start taking Skyclarys (omaveloxolone). These blood tests help check the health of your liver, heart, and cholesterol levels. Because Skyclarys (omaveloxolone) can cause side effects that affect these parts of your body, your provider will order these blood tests before you start the medication to make sure it's safe for you. Throughout treatment, they'll also regularly order these blood tests for you to get. Ask your provider if you have any questions about these blood tests, what they're used to check for, and your lab results.
Since FA is a genetic problem, there isn't a specific amount of time you'll need to take Skyclarys (omaveloxolone) for. Your provider will regularly follow up with you to see how you're doing with Skyclarys (omaveloxolone) treatment. You'll likely continue taking the medication as long as it's helping your FA symptoms and you're able to tolerate the side effects (e.g., headache, nausea, stomach pain).
Skyclarys (omaveloxolone) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Skyclarys (omaveloxolone) can raise your liver enzyme levels in the blood, which can be a sign of liver injury. You'll need to get blood tests done before you start Skyclarys (omaveloxolone) and during treatment so your provider can check your liver health. Although most people didn't have symptoms if they had higher liver enzyme levels during studies, watch out for any symptoms of serious liver problems while you're taking Skyclarys (omaveloxolone). Get medical help right away if you notice swelling of your stomach, stomach pain, yellowing of your skin or the whites of your eyes, stool changes (black, tarry, or bloody stools), dark or brown urine, or confusion. You might need to stop taking Skyclarys (omaveloxolone) to prevent further liver damage.
Skyclarys (omaveloxolone) might raise the brain natriuretic peptide (BNP) levels in your blood. BNP is a marker of heart function, and a rise in BNP levels can be a sign of heart failure. Keep in mind that heart failure is a common complication of FA. So, it's not clear whether these changes in BNP levels are due to Skyclarys (omaveloxolone) or heart complications of FA. Let your provider know if you currently have heart failure or have any symptoms of heart failure while taking Skyclarys (omaveloxolone). Look out for any shortness of breath; swelling in the legs, ankles, or feet; irregular heartbeat; trouble exercising; tiredness; or sudden weight gain.
Skyclarys (omaveloxolone) can raise your cholesterol levels. In studies, people had higher cholesterol levels within the first 2 weeks of starting Skyclarys (omaveloxolone). Then, their cholesterol levels went back to normal within 1 month after stopping the medication. Your provider will check your cholesterol levels before you start Skyclarys (omaveloxolone) and periodically during treatment. They might prescribe you medications to help manage your cholesterol levels if you need it.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 50mg of | 90 capsules | $0.00 | $0.00 |
The typical dose is 150 mg (3 capsules) by mouth once per day. The capsules are taken on an empty stomach at least 1 hour before eating food.
Your dose might differ if you have liver problems or if you're taking certain medications that interact with Skyclarys (omaveloxolone).